Medical Journals

In Vivo Osteogenic Potential of Human Adipose-derived Stem Cells/Poly Lactide-co-glycolic Acid Constructs for Bone Regeneration in a Rat Critical-sized Calvarial Defect Model.

Authors:
  • Yoon Eulsik
  • Dhar Sanjay
  • Chun Daniel E
  • Gharibjanian Nareg A
  • Evans Gregory R D

From: Aesthetic and Plastic Surgery Institute, Korea University Ansan Hospital, Danwon-gu, Ansan, Kyunggi-do, Korea.

Tissue engineering

  • Publish Date: Mar 2007
  • ISSN: 1076-3279
  • Volume: 13
  • Issue: 3
  • Pages: 619-27
  • Medium: Print
  • Language: English
  • Citation (JAMA): Yoon Eulsik, Dhar Sanjay, Chun Daniel E, et al. In Vivo Osteogenic Potential of Human Adipose-derived Stem Cells/Poly Lactide-co-glycolic Acid Constructs for Bone Regeneration in a Rat Critical-sized Calvarial Defect Model.. Tissue Eng. Mar 2007;13:619-27

Abstract

Recent studies suggest that human adipose tissue contains pluripotent stem cells, which are similar to bone marrow-derived stem cells. The objective of the present study was to assess the effect in bone regenerating capability of human adipose-derived stem cells (ADSCs) cultured in osteogenic media layered over poly lactide-co-glycolic acid (PLGA) and implanted in a critical nude rat calvarial defect. Twenty-seven nude rats were randomized into 3 groups (n = 9): 1) PLGA alone (control), 2) PLGA with undifferentiated ADSCs, and 3) PLGA with differentiated ADSCs. These 3 groups were divided into 9 subgroups (n = 3) according to in vitro pre-cultured periods (day 1 pre-culture (Group1), day 7 pre-culture (Group2), and day 14 pre-culture (Group3)) before implantation. An 8 mm critical-size circular calvarial defect was made in each nude rat. Specimens were harvested at 12 weeks post-implantation and evaluated radiographically and histologically. Radiodensitometric analysis revealed significantly higher bone growth in implants pre-cultured in osteogenic media for 14 days for Group 3. Histomorphometric analysis demonstrated that Groups 2 and 3 had bone formation filling 35% to 72% of the area of the defect after transplantation with cells that had been pre-cultured for 14 days. Constructs with differentiated ADSCs (Group 3) had noticeably more maximal and robust bone tissue regeneration than constructs with undifferentiated ADSCs (Group 2). These data provide evidence that constructs or implants made of PLGA and osteogenically differentiated ADSCs pre-cultured for 14 days before transplantation have better, more-robust bone regeneration capability in critical-sized skeletal defects than constructs with undifferentiated ADSCs. Human adipose derived stem cells can therefore be used as seed cells to construct tissue-engineered bone.

Mesh Headings (Keywords): Adipose Tissue, Animals, Biocompatible Materials, Bone Regeneration, Cells, Cultured, Glycolates, Humans, Osteogenesis, Rats, Rats, Nude, Skull, Stem Cell Transplantation


Check for Full Text / PubMed Unique Identifier (PMID): 17518608


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.